2014 marks the 20th anniversary of CyberKnife technology. Oklahoma CyberKnife is proud to commemorate this milestone.
Developed in 1994 at Stanford by Dr. John Adler, the concept was conceived with the goal of treating tumors throughout the body with radiosurgery, a treatment that at the time was restricted to head and neck tumors.
Over the last 20 years, CyberKnife has been adopted internationally for the treatment of primary and metastatic tumors, including those in the lungs, brain, kidney and prostate.
CyberKnife manufacturer, Accuray, reports that the system has been used in 40 countries to treat more than half a million patients to date. Over the last two decades, CyberKnife has evolved as a treatment method with expanded applications and the availability of long-term patient results to further demonstrate its efficacy.
To learn more about Oklahoma CyberKnife and how we treat different types of tumors and conditions, contact us.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.